Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation
These are typically mild to moderate in intensity, most often occur during dose escalation [24, 38, 39, 61, 62, 76,77,78,79,80,81,82], and most likely reflect the mechanism of action of semaglutide in terms of delaying gastric emptying and increasing satiety via a central action [56]
Care 46 , 384390
Tirzepatide produces 2122% weight loss in clinical trials, outperforming semaglutide in many patient populations
Weight loss occurs gradually over 3-6 months, whilst glycaemic improvements may become apparent within weeks of reaching optimal dosing
Branded Saxenda is no longer being manufactured